The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 127.50
Bid: 125.00
Ask: 130.00
Change: 0.00 (0.00%)
Spread: 5.00 (4.00%)
Open: 127.50
High: 127.50
Low: 127.50
Prev. Close: 127.50
TRT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Fundraising

21 Dec 2011 14:00

RNS Number : 4326U
Transense Technologies PLC
21 December 2011
 



Transense Technologies plc (the "Company")

 

21 December 2011

 

Result of Fundraising - £1,332,696 raised

 

The Company is pleased to report that it has received subscriptions under the Offer to Warrant holders for 22,243,240 Subscription Shares and accordingly will issue 11,121,606 Bonus Shares. The Company has also taken the opportunity, in response to investor demand, to issue a further 11,058,333 new ordinary shares of 1p each ("Ordinary Shares") at 3 pence per share to new and existing investors to raise, in aggregate, £1,332,696 (before expenses).

 

As previously announced, the proceeds of the Fundraising will be used to further develop the Company's strategy, and in particular to accelerate the pace at which it addresses the opportunities arising within the IntelliSAW division, and for general working capital purposes.

 

The new Ordinary Shares (including the Bonus Shares) to be issued pursuant to the Fundraising will be credited as fully paid and will rank pari passu with the existing Ordinary Shares, including the right to receive all dividends and other distributions declared, made or paid after the date of their issue.

 

The Company will apply for admission of the new Ordinary Shares to be traded on the AIM market of the London Stock Exchange. It is expected that Admission will take place and that trading will commence on 29 December 2011.

 

For the purposes of the Disclosure and Transparency Rules, the Company's total issued share capital following completion of the Fundraising will consist of 176,665,346 Ordinary Shares with one voting right per share. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

 

Capitalised terms used, but not defined in this announcement, have the same meanings as set out in the announcement released by the Company on 21 November 2011.

The Chairman, David Kleeman, said:

"We are very pleased by the level of support shown by shareholders in these challenging economic and market conditions. The Board believes that supported by the proceeds from the Fundraising, the Company is well on its way to generating significant income from its new revenue channels."

 

Contacts:

 

Transense Technologies PLC

Graham Storey 01869 238380

David Kleeman 020 7430 9329

 

Hybridan LLP - Financial adviser and Broker

Claire Noyce/Tim Goodman /Deepak Reddy- 020 7947 4350

 

Brewin Dolphin - Nominated Adviser

Neil Baldwin 0845 213 4730

ENDS

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAAAFASXFFFF
Date   Source Headline
31st Jan 20227:00 amRNSNotice of Results & Investor Presentation
23rd Dec 20212:51 pmRNSHolding(s) in Company
22nd Dec 20214:11 pmRNSDirector/PDMR Shareholding
7th Dec 20214:25 pmRNSDirector/PDMR Shareholding
30th Nov 20217:00 amRNSDirector/PDMR Shareholding - Acquisition of Shares
24th Nov 20217:00 amRNSDirector/PDMR shareholding – acquisition of shares
23rd Nov 202112:47 pmRNSResult of AGM
23rd Nov 20217:00 amRNSAGM Trading Update and Director Appointments
11th Nov 202111:40 amRNSHolding(s) in Company
2nd Nov 20217:01 amRNSAppointment of Additional SAWCAP Member
2nd Nov 20217:00 amRNSAGM Attendance & Investor Presentation
27th Oct 20217:00 amRNSAnnual Report, Notice of AGM & Investor Pres
4th Oct 20217:00 amRNSGrant of Options/PDMR Dealing
28th Sep 20217:00 amRNSFinal Results & Investor Presentation
14th Sep 20217:00 amRNS5 year JCA with McLaren Applied Ltd for SAW Tech
3rd Sep 20214:38 pmRNSHolding(s) in Company
31st Aug 20215:00 pmRNSTotal Voting Rights
26th Aug 20217:00 amRNSNotice of Annual Results & Investor Presentation
18th Aug 20213:30 pmRNSExercise of warrants
23rd Jul 20217:00 amRNSDirector/PDMR Shareholding
21st Jul 20217:00 amRNSNew member of Commercial Advisory Panel
5th Jul 20217:00 amRNSYear End Trading Update
2nd Jul 20211:12 pmRNSHolding(s) in Company
23rd Jun 20217:00 amRNSDirector/PDMR Shareholding
9th Apr 202110:05 amRNSHolding(s) in Company
15th Mar 20217:00 amRNSHolding(s) in Company
19th Feb 20214:12 pmRNSHolding(s) in Company
18th Feb 20211:21 pmRNSDirector/PDMR shareholding
17th Feb 202110:34 amRNSDirector/PDMR shareholding
17th Feb 20217:00 amRNSInterim Results & Investor Presentation
12th Feb 202112:48 pmRNSFurther re. Completion of Capital Reduction
1st Feb 20217:00 amRNSNotice of Results & Investor Presentation
28th Jan 20217:00 amRNSCompletion of Capital Reduction
21st Dec 20207:00 amRNSIssue of Options
17th Dec 20201:19 pmRNSResult of AGM
17th Dec 20207:00 amRNSAGM Update, new Website & Investor Presentation
9th Dec 20207:00 amRNSEstablishment of SAW Commercial Advisory Panel
23rd Nov 20207:00 amRNSPosting of Annual Report and Notice of AGM
6th Nov 20203:38 pmRNSDirector/PDMR Shareholding
22nd Oct 20208:45 amRNSHolding(s) in Company
20th Oct 202012:09 pmRNSDirector/PDMR Shareholding
20th Oct 20207:00 amRNSFinal results for the year ended 30 June 2020
19th Oct 20207:00 amRNSChange of Nomad and Broker & AIM Rule 17 update
12th Oct 20207:00 amRNSNotice of Results and Investor Presentation
10th Sep 20207:00 amRNSFinal consideration for iTrack transfer
25th Aug 202010:23 amRNSDirector/PDMR Shareholding
24th Aug 20209:27 amRNSHolding(s) in Company (Replacement)
20th Aug 20205:02 pmRNSHolding(s) in Company
8th Jul 20204:16 pmRNSDirector/PDMR Shareholding
7th Jul 20203:38 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.